Smith & Nephew SNATS (SNN)
(Real Time Quote from BATS)
$28.74 USD
+0.22 (0.77%)
Updated Jul 24, 2024 01:30 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Price, Consensus and EPS Surprise
SNN 28.74 +0.22(0.77%)
Will SNN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SNN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SNN
Should Value Investors Buy Smith & Nephew SNATS (SNN) Stock?
Smith & Nephew's (SNN) CATALYSTEM System Gets FDA Clearance
SNN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Smith & Nephew's (SNN) 5% Stake Acquired by Cevian Capital
Smith & Nephew's (SNN) CORIOGRAPH to Aid Arthroplasty Procedure
Smith+Nephew (SNN) Expands in Australia With New Alliance
Other News for SNN
GLOBAL BROKER RATINGS: CFRA cuts Tesla; LBBW likes Bechtle
Smith & Nephew initiated with bullish view at Deutsche Bank, here's why
LONDON BROKER RATINGS: Deutsche Bank starts Smith & Nephew at 'buy'
LONDON BRIEFING: Reckitt to simplify; Informa agrees Ascential buy
Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEMâ„¢ Primary Hip System